Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to… Click here to view original postCalibr-Skaggs is seeking exceptionally talented Associate Director candidates to lead the protein sciences team within the biologics drug discovery group… Click here to view original postPerform high-throughput profiling assays to support small molecule drug discovery projects. Optimize and miniaturize assays to enable HTS. $81,000 -… Click here to view original postBachelor’s Degree or equivalent experience in physics, biotechnology, bioengineering, electronics, biochemistry, or related field. $85,000 – $90,000 a yearFrom Mesa… Click here to view original postSAN DIEGO, June 26, 2024 /PRNewswire/ — Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced the additions of two industry-leading artificial intelligence and portfolio management experts to its executive team. [...]The Senior Bioinformatics Engineer position contributes to the development and support of both on-market products and new product development, with… Click here to view original postThe FDA’s director of its Office of Medical Policy wants trial sponsors to keep participant experiences top-of-mind in their decentralized designs. Endpoints News sat down with Khair ElZarrad last week in San Diego at the [...]Chief Administrative Officer for Health Justice, Equity, Diversity and Inclusion discusses how her childhood influences mission to confront health disparities. Click here to view original post Click Here to Publish/Feature Your Company or Product News [...]SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) — In a release issued under the headline “Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy” on Tuesday, June 25th by Capricor Therapeutics, please note that [...]Over three decades, the Hellman family has given over $18 million to support more than 400 UC San Diego junior faculty in their research and progress toward tenure. Click here to view original post Click [...]SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the U.S. Food and Drug [...]